BridgeMD
New treatment option for Morbid Obesity
Official title Dual-chamber Patient-controlled Analgesia for Postoperative Recovery
ClinicalTrials.gov ID: NCT07051109
What this study is testing
- What it's testing
- Postoperative nausea and vomiting (PONV) are the most common complications that can occur after general anesthesia. Postoperative use of opioids and morbid obesity have been reported as risk factors of PONV.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 65, women only
You may be able to join if
- Adult females aged 19 to 65 years
- American Society of Anesthesiologists physical status (ASA class) 1 to 3
- Patients scheduled for laparoscopic sleeve gastrectomy under general anesthesia
- Patients requesting the use of IV-PCA after surgery
You likely can't join if
- Patients with hypersensitivity to the drugs used in this study (Ketorolac, Fentanyl)
- Patients with alcohol or drug dependence, long-term use of opioids or analgesics
- Patients with liver disease or renal failure
- Patients with peptic ulcer, patients with gastrointestinal bleeding predisposition
- Patients with suspected cerebrovascular hemorrhage, organic disorders of the head related to increased intracranial pressure
- Patients with bronchial asthma or bronchospasm symptoms
See the full eligibility criteria
- Adult females aged 19 to 65 years
- American Society of Anesthesiologists physical status (ASA class) 1 to 3
- Patients scheduled for laparoscopic sleeve gastrectomy under general anesthesia
- Patients requesting the use of IV-PCA after surgery
- Patients with hypersensitivity to the drugs used in this study (Ketorolac, Fentanyl)
- Patients with alcohol or drug dependence, long-term use of opioids or analgesics
- Patients with liver disease or renal failure
- Patients with peptic ulcer, patients with gastrointestinal bleeding predisposition
- Patients with suspected cerebrovascular hemorrhage, organic disorders of the head related to increased intracranial pressure
- Patients with bronchial asthma or bronchospasm symptoms
- Patients with severe respiratory depression
- Nasal polyps, angioedema
- Patients with or history of convulsive disease
- Patients for whom the use of neuromuscular blocking agents is contraindicated
The study team makes the final eligibility decision.
Where it's taking place
- Seongnam-si, Gyunggi-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 19 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seongnam-si, Gyunggi-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.